Erica Lazlo has entered stage two kidney and liver failure and says she has "accepted her fate" and is putting together a ...

A Yale School of Medicine team has created lists of criteria to help clinicians determine when next-generation sequencing ...

Scemblix resulted in better outcomes and fewer side effects compared to standard tyrosine kinase inhibitor therapies in ...

Medically reviewed by Doru Paul, MD Leukemia is a cancer that changes blood cells. It usually develops in the bone marrow, ...

Adverse events associated with ponatinib in CML and ALL were shown to have decreased significantly since its approval, ...

A retrospective analysis reveals that tyrosine kinase inhibitors offer a promising pathway for managing chronic myeloid leukemia in patients ages 75 and older, with increases in major molecular ...

The Sunrise star, 41, revealed that she had been diagnosed with chronic myeloid leukaemia (CML) - a type of blood and bone marrow cancer - live on air in September. Edwina was first diagnosed in ...

A new method can improve treatment for patients with chronic myeloid leukemia by predicting which medication will be most ...

US regulators’ use of a speedy clearance pathway for a new frontline indication for asciminib for chronic myeloid leukemia ...

Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global unmet medical needs primarily for malignancies, today ...